Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing

Abstract

loading...

About

This paper, published in 1950, received 497 indexed citations. Written by Kelly A. Birdwell, Brian S. Decker, Catherine M. Stein, Wolfgang Sadée, Daqing Wang, Alexander A. Vinks, Yijing He, JJ Swen, JS Leeder and RHN van Schaik covering the research area of Pediatrics, Perinatology and Child Health, Pharmacology and Transplantation. It is primarily cited by scholars working on Transplantation (277 citations), Pediatrics, Perinatology and Child Health (257 citations) and Pharmacology (227 citations). Published in Clinical Pharmacology & Therapeutics.

In The Last Decade

doi.org/10.1002/cpt.113 →

Countries where authors are citing Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing

Since Specialization
Citations

This map shows the geographic impact of Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing more than expected).

Fields of papers citing Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1002/cpt.113.

Explore hit-papers with similar magnitude of impact

Breakdown of academic impact, for the paper Deep learning in histopathology: the path to the clinic Breakdown of academic impact, for the paper The Conquest of American Inflation Breakdown of academic impact, for the paper Possible artifacts of data biases in the recent global surface warming hiatus Breakdown of academic impact, for the paper Obesity in autoimmune diseases: Not a passive bystander Breakdown of academic impact, for the paper Reflection: a review of the literature Breakdown of academic impact, for the paper Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials Breakdown of academic impact, for the paper Strategy or identity: New theoretical paradigms and contemporary social movements Breakdown of academic impact, for the paper EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis
Rankless by CCL
2026